| Literature DB >> 28492484 |
Hui Tan1, Tamrakar Sonam2, Kuniyoshi Shimizu3.
Abstract
The leaves of loquat (Eriobotrya japonica) possess high medicinal value and have been used as traditional medicines. However, there are no evidence-based studies on the skin-care effects of E. japonica leaves. To explore new biological activities of E. japonica leaves against skin disorder and to gain a better understanding of the chemical components associated with bioactivities, we evaluated 18 triterpenoids from E. japonica leaves on anti-melanogenesis, anti-acne, anti-allergy and anti-aging activities. Our results revealed that eight compounds showed anti-melanogenesis activity, of which ursolic acid (1) and maslinic acid (7) were the most potent with the similar selective index to that of arbutin. Structure-activity relationship and possible mechanism of active compounds were proposed. Twelve compounds exhibited anti-acne effect; ursolic acid (1), maslinic acid (7), corosolic acid (8) and euscaphic acid (12) showed highest activities against P. acnes. Four compounds displayed anti-allergy and anti-inflammatory activity; 3-epicorosolic acid (9) and euscaphic acid (12) showed marked activity against β-hexosaminidase release. Finally, ursolic acid (1), pomolic acid (10), colosolic acid (8) and its methylated derivative (6) exhibited the highest anti-aging activity by stimulating collagen and hyaluronic acid (HA) production. Our findings provide valuable evidence that E. japonica leaves have potential applications as ingredients of function foods or cosmetics for health benefits and a number of triterpenoids may play an important role in these bioactivities.Entities:
Keywords: Eriobotrya japonica; anti-acne; anti-aging; anti-allergy; anti-melanogenesis; loquat leaves; skin disorder; triterpenoids
Mesh:
Substances:
Year: 2017 PMID: 28492484 PMCID: PMC5454942 DOI: 10.3390/ijms18051030
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The structures of the 18 tested triterpenoids from E. japonica leaves.
Anti-melanogenesis effect of triterpenoids from E. japonica leaves.
| No. | CC50 a (μM) | IC50 b (μM) | S.I c | No. | CC50 (μM) | IC50 (μM) | S.I e |
|---|---|---|---|---|---|---|---|
| 9.4 | 4.8 | 1.9 | 10.5 | 14.0 | 0.8 | ||
| 39.9 | 26.8 | 1.5 | 23.3 | 18.5 | 1.3 | ||
| >45.2 | >45.2 | n.d. d | 25.6 | 34.0 | 0.7 | ||
| 16.7 | 11.8 | 1.4 | 8.9 | 18.0 | 0.5 | ||
| 17.5 | 12.8 | 1.4 | 10.9 | 14.8 | 0.7 | ||
| 18.7 | 16.1 | 1.2 | >42.3 | >42.3 | n.d. | ||
| 29.3 | 18.5 | 1.9 | 16.5 | 21.6 | 0.8 | ||
| 25.8 | 18.7 | 1.4 | 24.0 | >30.9 | n.d. | ||
| >42.3 | >42.3 | n.d. | 19.5 | >30.9 | n.d. |
a The CC50 value is defined as the cytotoxic concentration causing death in 50% of viable cells, and is calculated from the corresponding dose–response curves (for the individual concentrations see Table S1); b The IC50 value is defined as the concentration required for 50% inhibition of melanin synthesis, and is calculated from the corresponding dose–response curves (for the individual concentrations see Table S2); c The selectivity index (S.I.) was calculated as the ratio of the concentration of the compound that is required to reduce the cell viability to 50% to the concentration of the compound needed to inhibit melanogenesis to 50% of the control value (i.e., the CC50 value/IC50 value); d n.d.: non-detectable; e Arbutin was used as a positive control, its S.I was calculated as 1.9.
Figure 2The effect of active compounds on tyrosinase activity (with respect to L-tyrosine). The inhibition curve of each compound was calculated under their maximum solubility of 330 μg/mL. Kojic acid is positive control.
Anti-acne effect of triterpenoids from E. japonica leaves.
| No. | Concentration μg/mL | Inhibition Rate % | MIC a/MBC b μg/mL | No. | Concentration μg/mL | Inhibition e Rate % | MIC/MBC μg/mL |
|---|---|---|---|---|---|---|---|
| 100 | 109.8 ± 0.5 | 50/100 | 100 | 84.4 ±1.2 | n.d. | ||
| 100 | 100.4 ± 0.8 | 100/200 | 100 | 102.8 ± 2.1 | 100/200 | ||
| 50 | – c | – | 100 | 98.5 ± 1.3 | 50/50 | ||
| 100 | – | – | 100 | – | – | ||
| 100 | – | – | 100 | 87.6 ± 7.4 | n.d. | ||
| 100 | 77.9 ± 1.6 | n.d. d | 100 | – | – | ||
| 100 | 104.1 ± 3.1 | 50/150 | 100 | 103.9 ± 3.1 | 100/200 | ||
| 100 | 105.9 ± 0.4 | 50/100 | 100 | 101.4 ± 2.1 | 100/200 | ||
| 100 | – | – | 100 | 103.5 ± 2.2 | 100/200 |
a The minimum inhibitory concentration (MIC) is the lowest concentration of an anti-bacterial agent required to completely inhibit the growth of a particular bacterium; b The minimum bactericidal concentration (MBC) is the lowest concentration of an antibacterial agent required to kill the bacterium; – c : no inhibition; n.d. d : non-detectable; e Benzalkonium chloride was used as the positive control and showed 100% inhibition of bacterial growth at the conc. of 200 μg/mL.
Anti-allergy and anti-inflammatory effects of triterpenoids from E. japonica leaves.
| No. | IC50 (μM) | 25 μg/mL | 12.5 μg/mL | 5 μg/mL | 1 μg/mL |
|---|---|---|---|---|---|
| Inhibition Rate (%) | |||||
| 39.5 | 72.5 ± 3.0 ** | 37.6 ± 3.0 * | 0.0 ± 11.5 | n.d. | |
| 22.8 | 66.0 ± 2.6 * | 58.2 ± 3.0 * | 9.5 ± 6.6 | n.d. | |
| 14.2 | 54.4 ± 4.9 * | 50.7 ± 3.2 * | 33.7 ± 6.9 | 8.9 ± 5.2 | |
| 15.8 | 74.5 ± 1.3 ** | 67.0 ± 1.8 ** | 37.7 ± 3.9 * | 10.4 ± 10.8 | |
Quercetin was used as the positive control and showed the inhibition rate of β-hexosaminidase release of 72.5 ± 3.0% without cytotoxicity at 82 μM. n.d.: non-detectable. * p < 0.05 and ** p < 0.01.
Figure 3Collagen production (CP)—promoting effects of triterpenoids from leaves of E. japonica leaves. Data are the means ± SD of three independent tests, and all data were calculated as the percentage compared with the control value. Ascorbic acid (100 μM) was used as a positive control. * The promoting ratio (or CP/CV value) represents the mean of collagen production (%)/the mean of cell viability (CV) (%).
Figure 4Stimulatory effects of triterpenoids from E. japonica leaves on hyaluronic acid (HA) production. Data are the means ± SD of three independent tests, and all data were calculated as percentages compared with the control values. Ascorbic acid (100 μM) was used as a positive control. * The promoting ratio (or HA/CV value) represents the mean of hyaluronic acid (%)/the mean of cell viability (%).
| Compound | R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 |
|---|---|---|---|---|---|---|---|---|
| β–OH | H | H | COOH | Me | H | H | Me | |
| β–OH | H | H | COOH | H | H | Me | Me | |
| β–OH | H | H | CH2OH | Me | H | H | Me | |
| β–OH | OH | H | COOCH3 | H | H | Me | Me | |
| β–OH | OH | H | COOCH3 | Me | H | H | Me | |
| β–OH | OH | H | COOH | H | H | Me | Me | |
| β–OH | OH | H | COOH | Me | H | H | Me | |
| α–OH | OH | H | COOH | Me | H | H | Me | |
| β–OH | H | H | COOH | Me | OH | H | Me | |
| β–OH | OH | H | COOH | Me | OH | H | Me | |
| α–OH | OH | H | COOH | Me | OH | H | Me | |
| =O | H | H | COOH | Me | H | H | Me | |
| =O | H | OH | COOH | Me | OH | H | Me | |
| =O | OH | H | COOH | Me | OH | H | Me | |
| β– | OH | H | COOH | Me | OH | H | Me | |
|
| β– | OH | H | COOH | Me | OH | H | Me |